Daniel Lundel

Targeting CXCR3 reduces ligand-induced T-cell activation but not development of lung allergic responses.

E. Gelfand, K. Takeda, J. Fine, 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.